Journal of Inherited Metabolic Disease

, Volume 33, Supplement 3, pp 21–24 | Cite as

Xanthine dehydrogenase deficiency with novel sequence variations presenting as rheumatoid arthritis in a 78-year-old patient

  • Agnieszka Jurecka
  • Blanka Stiburkova
  • Jakub Krijt
  • Wanda Gradowska
  • Anna Tylki-Szymanska
Research Report



This report describes the clinical, biochemical and molecular data of a 78-year-old patient with xanthine dehydrogenase deficiency presenting as rheumatoid arthritis.


Xanthinuria type I is a rare disorder of purine metabolism caused by xanthine dehydrogenase (XDH) deficiency; fewer than 150 cases have been described in the literature so far.


We describe the clinical history and urine and serum findings of a 78-year-old patient with isolated XDH deficiency presenting as rheumatoid arthritis. The diagnosis was confirmed by mutation analysis.


The patient suffered from arthral symptoms and nephrocalcinosis. Very low concentrations of uric acid were observed in her serum and urine. The allopurinol loading test indicated her xanthinuria to be type I. Analysis of genomic DNA revealed novel heterozygous deletion in exon 8 (g.27073delC, p.214QfsX4) and previously published heterozygous nucleotide missense transition in exon 25 (g.64772-C>T, p.T910M).


Hereditary xanthinuria is a rare disorder, but it also needs to be considered in patients not originating from Mediterranean countries or the Near or Middle East. Urate concentration in serum and urine may provide an initial indication of XDH deficiency before high-performance liquid chromatography (HPLC) analysis is performed. The key to identifying the disorder is a greater awareness of XDH deficiency amongst primary care physicians, nephrologists, and urologists, but also rheumatologists. The diagnosis and therapeutic management requires a multidisciplinary approach.


Uric Acid Xanthine Allopurinol Serum Uric Acid Flavin Adenine Dinucleotide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



gas chromatography–mass spectrometry


high-performance liquid chromatography


uric acid


xanthine dehydrogenase



This study was supported by Research Project from the Ministry of Education, Youth and Sports of the Czech Republic, MSM 0021620806, by grant MZ0VFN2005 from the Ministry of Health of the Czech Republic and grant PB 1121/P01/2007/32 from the Polish Scientific Research Committee.


  1. Arikyants N, Sarkissian A, Hesse A, Eggermann T, Leumann E, Steinmann B (2007) Xanthinuria type I: a rare cause of urolithiasis. Pediatr Nephrol 22:310–314PubMedCrossRefGoogle Scholar
  2. Blake DR, Stevens CR, Sahinoglu T et al (1997) Xanthine oxidase: four roles for the enzyme in rheumatoid pathology. Biochem Soc Trans 25:812–816PubMedGoogle Scholar
  3. Bradford MJ, Hrehorovich V (1969) Xanthinuria, psoriasis and arthritis. Am J Med 46:137–141PubMedCrossRefGoogle Scholar
  4. Engelman K, Watts RW, Klinenberg JR, Sjoerdsma A, Seegmiller JE (1966) Clinical physiological exercise and biochemical studies of a patient with xanthinuria and pheochromocytoma. Am J Med 37:836–861Google Scholar
  5. Freudweiler M (1901) Experimentelle Untersuchungen uber die Entstchung der Gichtknoten. Deutches Arch Klin Med 69:155Google Scholar
  6. Gok F, Ichida K, Topaloglu R (2003) Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria. Nephrol Dial Transplant 18:2278–2283PubMedCrossRefGoogle Scholar
  7. Ichida K, Yoshida M, Sakuma R, Hosoya T (1998) Two siblings with classical xanthinuria type I: significance of allopurinol loading test. Intern Med 37:77–82PubMedCrossRefGoogle Scholar
  8. Klocke R, Mani AR, Moore KP, Blake DR, Mapp PI (2005) Inactivation of xanthine oxidoreductase is associated with increased joint swelling and nitrotyrosine formation in acute antigen-induced arthritis. Clin Exp Rheumatol 23:345–350PubMedGoogle Scholar
  9. Raivio KO, Saksela M, Lapatto R (2001) Xanthine oxidoreductase: role in human pathophysiology and in hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited diseases. McGraw-Hill, New York, pp 2639–2652Google Scholar
  10. Shibutani Y, Ueo T, Yamamoto T, Takahashi S, Moriwaki Y, Higashino K (1999) A case of classical xanthinuria (type 1) with diabetes mellitus and Hashimoto’s thyroiditis. Clin Chim Acta 285:183–189PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer 2010

Authors and Affiliations

  • Agnieszka Jurecka
    • 1
  • Blanka Stiburkova
    • 2
  • Jakub Krijt
    • 2
  • Wanda Gradowska
    • 3
  • Anna Tylki-Szymanska
    • 1
  1. 1.Department of Metabolic Diseases, Endocrinology and DiabetologyThe Children’s Memorial Health InstituteWarsawPoland
  2. 2.Institute for Inherited Metabolic DisordersCharles University, 1st Faculty of MedicinePragueCzech Republic
  3. 3.Department of Biochemistry and Experimental MedicineThe Children’s Memorial Health InstituteWarsawPoland

Personalised recommendations